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compared with a non-coated bare stent, one month after inplantation. 
In this pilot tdal, 21 patients (mean age:62+/-9 years) with a recurrent in-stent restenosis 
were treated with a single 60pg paclitaxel coated stent. Fourteen pts were males, 6 dia- 
betic, and 13 were treated for hypercholesteroJemia. All inplants were sucoessfulL All 
patients recieved Ticlopidine (250mg) during 3months.There were no major in-hospital 
complications. At follow-up two pts experienced a subacuta thrombotic occlusion of the 
stentad artery. One after 14 days under ticlopidine treatment and one after 4m when the 
ticlopidine treatment was already stopped for 3 weeks. Three patients underwent an 
early control coronarography because of recurrence of symptoms. One showed an in- 
stent rastenosis in the paclitaxel coated stent. All remaining patients underwent a control 
ooronarogram at 6 months follow-up. Two additional patients showed a significant in- 
stant restenosis. 
Conclusion: Paclitaxel eluting stents to treat in-stant restenosis is a promissing new treat- 
ment modality. Late trombotio stant occlusion due to retarded endothelial cell regrewth is 
however a concern and prolonged antiplatelet reatment seems to be mandatory. 
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1175-1 Mechanisms of Lumen Narrowing of Saphenous Vein 
Bypass Grafts 12 Months After Implantation: An 
Intravascular Ultrasound Study 
Hideaki Kaneda, Mitsuyasu Terashima, Takefumi Takahashi, Stein Iversen, Thomas 
Felderhoff, Eberhard Grube, Paul G. Yock, Peter J. Fitzgerald, Yasuhiro Honda, Stanford 
Universi~ Stanford, California, Heart Center Siegburg, Siegburg, Germany. 
Background: Diseased saphenous vein bypass grafts (SVG) several years after surgery 
have been shown to undergo vascular remodeling similar to native coronary arteries. 
However, little in vivo data exist as to the early morphologic changes of SVG. The aim of 
this study was to examine whether the remodeling process occurs in SVG in the early 
phase. 
Methods: We studied 30 SVG by IVUS using automated pullback 12 months after 
implantation. In all cases, IVUS images were analyzed between 10 and 60 mm from the 
proximal anastomosis. Lumen (LA), intima (IA), and vessel areas (VA, defined as the 
area within the outer border of a hypoechoic intima[ layer) were computed. Quantitative 
analysis was performed at 3 cross-sections: the minimum lumen area (MLA) site with the 
smallest lumen area, and the proximal and distal reference sites with the least intimal 
burden within 10 mm from the MLA site. Area changes (4) were calculated as the MLA 
site minus the average of the reference sites. 
Results: In this cohort, 70% of the MLA sites had a smaller VA than the references, indi- 
cating inadequate compensatory remodeling in the majority of SVG. Overall, VA at the 
MLA sites was significantly smaller than the references (9.7+~.9 vs 11.C~_3.2 mm 2, 
p<0.0001), despite the smaller LA (7.2±2.6 vs 9.5~2.9 mm 2, p<0.0001) with a larger IA 
(2.5±2.1 vs 1.2±1.3 mm 2, p<0.0001) at the MLA site. The relative contributions of AVA (- 
1.0±1.4 mm 2) and ~IA (1.3±1.3 mm 2) to lumen compromise (-2.3±1.4 mm 2) were 43% 
and 57%, respectively. On the other hand, simple linear regression analysis revealed a 
significant positive correlation between AIA and AVA (y=-1.7+0.52x, r=0.50, p=0.005). 
Conclusions: The mechanism of early lumen compromise in SVG may be a combina- 
tion of entire vessel narrowing and intimal hyperplesia. However, positive remodeling 
process appeared to remain to compensate for excessive intimal proliferation. These 
findings may be important to incorporate when evaluating biological techniques for 
improving long-term graft patency. 
11 75-2 Determinants of Carotid Artery Size: An Intravascular 
Ultrasound Analysis 
Georae K. Daniel. Nell J. Weissman, Gary S. Mintz, Daniel A. Canos, Dancia Langley, 
Lowell F. Satler, John R. Laird, Washington Hospita/Center, Washington, Dist. of 
Co/umbia. 
Background: During carotid interventions, a wide range of carotid size is noted. Coro- 
nary luminal dimensions are dependent on body size, gender and the presence of diffuse 
disease however; the determinants of carotid size are unknown. Methods: We evaluated 
carotid artery size using intravascular ultrasound (IVUS) in 83 pts (55 men) prior to 
carotid intervention. External elastic membrane (EEM) and luminal cross sectional area 
(CSA) were measured at a non-stenotic common carotid artery (CCA) segment. Body 
size (BSA=body surface area) and other demographic information were systematically 
collected. Univariant and multivadant analysis was performed. Results: Patient age, 
hypertension, diabetes, hypercholestarolemia and tobacco use were not related to 
carotid size. Men had larger CCA EEM and lumens compared to women (p = .001). On 
univariant analysis, CCA size was also strongly related to body size (p = < .0001 ). 
Male Female p value 
EEM-CSA (mm 2) 67±14 56±13 0.001 
Lumen-CBA (mm 2) 39±10 32_+11 0.008 
EEM-CSA/BSA (rem 2) 34_+7 33±7 0.363 
Lumen-CSA/BSA (mm 2) 20±5 19_+7 0.502 
However, on multivariant analysis BSA was the only independent predictor of carotid 
size. Conclusion: Although carotid arteries are larger in men and are proportionate to 
body size, body size is the primary determinant of both carotid EEM and lumen size. 
1175-21 Gold-Coated Versus Uncoated Stents: An Intravascular 
Ultrasound Volumetric Analysis Showing an Increase in 
InUmal Hyperp las ia  in Gold-Coated Stents  
Andrea S. Abizaid, Alexandre Abizaid, Igor Mattos, Gary S. Mintz, Rodolfo Staico, Marco 
Costa, Ana C. Seixas, J. Eduardo de Paula, Aurea Chaves, Madnella Centemero, Luiz E 
Tanajura, Roxana Mehran, Amanda Sousa. J. Eduardo Sousa, Institute Dante 
Pazzanese of Cardiology, Sad Pau/o, Brazi/, Lenox Hi//Heart and Vascular Institute, 
Cardiovascu/ar Research Foundation, New York, New York. 
Background: Gold-coated (GC) stents enhance radiopacity which is extremely useful 
when precise stant placement is required. However, GC stents may cause reactive 
neointimal hyperplasia due to stent surface alterations. Previous studies have shown 
trend toward higher clinical and angiographic recurrence after GC stenting compared to 
stainless-steel (SS) stants. Methods: We randomized 48 patients with coronary artery 
disease to receive either a GC NIROYAL stent (n=24) or SS NIR PRIMO stent (n=24). All 
patients had angiography and intravascular ultrasound (IVUS) follow-up at six months 
Results: Baseline and angiographic characteristics were similar between the two 
groups. At 30 days, there was no sub-acute thrombosis in either group. Six-month IVUS 
results are shown in the table. At 6-months, target lesion revascularization was 26.1% in 
the GC group vs. 13.6% in the SS group (p=0.45). 
GC Stent SS stant p 
Conclusions: GC stants are associated with more neointimal hyperplasia by volumetric 
IVUS analysis at 6-months compared to SS stents, resulting in a trend toward higher clin- 
ical recurrence. Larger randomized trials are needed to demonstrate any equivalence 
between GC and SS stents. 
1175-22 Improvement  of  Microvascular Function in Chronic 
Coronary Occlusions Within Six Months After 
Recanalization: Influence of Diabetes and Hypertension 
Gerald S. Wemer. Markus Ferrari, Oliver Gastmann, Barbara M. Richartz, Hans R. 
Figulla, Klinik /nnere Medizin I//, Jeca, Germany. 
Micrevascular dysfunction (MD) after PTCA may cause a reduced coronary flow velocity 
reserve (CFVR) even after optimum treatment of the epicardial lesion. The present study 
evaluated the prevalence of MD in total chronic coronary occlusions (TCO), and a poten- 
tial recovery dudng followup. 
In 64 patients with successful recanalization and stenting of a TCO (minimum duration 1 
months; mean 5 months) a Doppler wire was used to assess CFVR after stent placement 
by measuring average peak velocity (APV) during hyperemia induced by i.c. 30 g ade- 
nosine, in addition the fractional flow reserved (FFR) was measured by an i.c. pressure 
wire. Patients were reexamined after 5.5±1.4 months. CFVR was obtained in 54 pts; 10 
pts were not reevaluated because of a raocclusion; in 19 pts with restenosis CFVR was 
obtained after repeat PTCA. MD was defined by CFVR<2.0 and FFR 0.75. 
CFVR after PTCA was 1.94±0.64. It was <2.0 in 56%, whereas FFR<0.75 was observed 
in only 8%, indicating MD in 48%. At followup CFVR increased to 2.28±0.82 (p=0.002) 
with a decrease of basal APV from 29±15 to 24±15 cm/s (p<0.05) and no change of max- 
imum hyperemic APV. At followup MD was observed in only 23%. The ejection fraction 
had improved from 53±20 to 60±18% (p<0.001), and the regional dysfunction was like- 
wise improved. CFVR after PTCA improved both in patients with normal regional function 
as well as with severely impaired regional function. CFVR improved also in patients with 
restenosis and repeat PTCA. 73% of patients had either diabetes and/or hypertension. 
They had a lower CFVR after PTCA as compared with those without eomorbidity 
(1.83±0.68 vs 2.17±0.44; p<0.05). The CFVR at followup was 2.18±0.79 and 2.55±0.84, 
respectively. The difference in CFVR, and of MD, was still observed in patients with dia- 
betes and/or hypertension (ANOVA p=0.067). 
Microvascular dysfunction is observed in 50% of patients with TCO. During 6 months fol- 
Iowup CFVR improved significantly as indicator of a restored MD. The improvement 
occurred independent of regional dysfunction and the incidence of restenosis. However, 
MD appeared to improve less and remained impaired in patents with diabetes and/or 
hypertension. 
IVUS @ 6-months 
Stant volume, mm 3 134.7 ± 62.5 148.1 ± 94.7 0.66 
Mean stent area, mm 2 7.5±1.8 8.0~3.3 0.58 
Lumen volume, mm 3 87.2 ± 44.9 102.0 + 75.8 0.30 
Mean lumen area, mm 2 4.2+1.7 5.6_+3.2 0.18 
Intimal hyperplasia volume, mm 3 57.9 ± 29.9 45.8 ± 30.6 0.30 
Mean Intimal hyperplasla ares, mm 2 3.6±1.5 2.4_+1.0 0.02 
In-stent obstruction, % 45.2 _+ 18.9 32.8 _+ 13.8 0.05 
